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ABSTRACT 
One of the mitogen-activated protein kinases, p38α plays a crucial role in various inflammatory 
diseases and apoptosis of various types of cells. In this study, we investigated the 
pathophysiological roles of p38α in spinal cord injury (SCI), using a mouse model. Lateral 
hemisection at T9 of the SC was performed in wild type (WT) and p38α+/− mice (p38α-/- showed 
embryonic lethality). p38α+/− mice showed a better functional recovery from SCI-associated 
paralyzed hindlimbs compared to WT mice at 7 days post-injury (dpi), which remained until 28 dpi 
(an end time point of monitoring the behavior). In histopathological analysis at 28 dpi, there was 
more axonal regeneration with remyelination on the caudal side of the lesion epicenter in p38α+/− 
mice than in WT mice. At 7 dpi, infiltration of inflammatory cells into the lesion and expression of 
cytokines in the lesion were reduced in p38α+/− mice compared with WT mice. At the same time 
point, the number of apoptotic oligodendrocytes in the white matter at the caudal boarder of the 
lesion of p38α+/− mice was lower than that of WT mice. At 14 dpi, more neural and oligodendrocyte 
precursor cells in the grey matter and white matter, respectively, were observed around the lesion 
epicenter of p38α+/− mice compared with the case of WT mice. At the same time point, astrocytic 
scar formation was less apparent in p38α+/− than in WT mice, while compaction of inflammatory 
immune cells associated with the wound contraction was more apparent in p38α+/− than in WT mice. 
Furthermore, we verified the effectiveness of oral administration of SB239063, a p38α inhibitor on 
the hindlimb locomotor recovery after SCI. These results suggest that p38α deeply contributes to 
the pathogenesis of SCI and that inhibition of p38α is a beneficial strategy to recovery from SCI. 
 
INTRODUCTION 
Spinal cord injury (SCI) results in limited motor function recovery under the chronic phase, 
mainly because of the poor regenerative capability of adult mammalian central nervous system 
(CNS) (Horner PJ, et al., 2000). SCI is composed of three phases, acute, secondary and chronic, and 
its outcomes are influenced by the secondary phase (Oyinbo CA, 2011). The secondary phase is 
characterized by inflammation-triggered events as follows: edema, apoptosis of cells including 
neurons and oligodendrocytes, demyelination, astrocytic scar formation and so on (Zhou X, et al., 
2014). Under the secondary phase of SCI, gradual functional recovery is observed in several 
animals including humans, the extent of which is inversely related to the intensity of primary 
damage. (Becker D, et al., 2003). It is thus logical to postulate that reduction of secondary damage 
waves by controlling inflammation-triggered events may improve the functional recovery after SCI. 
p38 is one of mitogen-activated protein kinases (MAPKs) which transduces a variety of 
extracellular signals to the transcriptional machinery. By using genetically engineered mice, it has 
been demonstrated that p38 participates at least in inflammatory responses and cell fate decision 
including apoptosis (Ventura JJ, et al., 2007; O’keefe SJ, et al., 2007; Kang YJ, et al., 2008; Risco A, 
et al., 2012). Among four mammalian isoforms of p38 (α, β, γ and δ), p38α is expressed 
ubiquitously in adult tissues and functions as a central player of p38 isoforms (Kumar S, et al., 
2003). Although p38α gene (MAPK14) deficiency results in lethality in homozygous embryonic 
mice, the p38α+/- mouse is a useful tool for studying the in vivo role of p38α in certain disease 
models (Tamura K, et al., 2000; Takanami-Ohnishi Y, et al., 2002; Matsuo Y, et al., 2006). In 
particular, p38α+/- mice show an outstanding resistance to neurodegenerative diseases such as 
epileptic seizure and experimental autoimmune encephalomyelitis (EAE, an animal model of 
multiple sclerosis associated with demyelination in the SC) (Namiki K, et al., 2007; 2012). In 
contrast, the deterioration of EAE was observed in transgenic mice expressing a constitutive active 
form of MKK6, a p38-specific activator (Noubade R, et al., 2011). Furthermore, self-renewal 
activity and neural differentiation capacity of neural stem cells (NSCs) in the hippocampus of 
p38α+/- mice are higher than those of WT mice (Yoshioka K, et al., 2015). These previous findings 
tempt us to think that inhibition of p38α may be beneficial to the functional recovery after SCI. In 
fact, it has been demonstrated that a p38α inhibitor, SB203580 could reduce the damage of 
hindlimb function after SCI (Horiuchi H, et al., 2003). In contrast, another group showed that 
SB203580 failed to improve functional outcome after SCI (Stiring DP, et al., 2008). Those reports 
are fully controversial though employing a similar SCI protocol and a same administration 
procedure. Therefore, whether p38α is recognized as a potential therapeutic target in SCI is still 
under debate. 
Here, we first showed that the hindlimb locomotor behavior was improved in p38α+/- mice 
compared to WT mice. As the mechanisms underlying the improved signs of SCI in p38α+/- mice, 
various pathological aspects under the secondary phase of SCI were examined between WT and 
p38α+/- mice. We finally showed that oral administration of SB239063, a p38α-specific inhibitor 
might be beneficial to functional recovery after SCI. 
 
 
 
MATERIALS AND METHODS 
Animals 
All animal procedures conformed to the Japanese regulations for animal care and use, following 
guideline for Animal Experimentation of the Japanese Association for Laboratory Animal Science, 
and were approved by the Animal Care and Use Committee of Chiba University. Male mice 
heterozygous for targeted disruption of the p38  gene (Tamura K, et al., 2000) were crossed with 
C57BL6J female mice (Tokyo Experimental Animal Co., Tokyo, Japan) to generate p38
+/-
 and 
p38
+/+
 (Wild type (WT)) mice. Genotyping by PCR analysis of tail-derived DNA was performed 
according to our previous report (Takanami-Ohnishi Y, et al., 2002).  
 
SCI model 
Male WT and p38
+/-
 mice aged 10-14 weeks were used for each experiment. Mice were deeply 
anesthetized with isoflurane. Laminectomy was performed at the thoracic levels of T8-10 to expose 
the spinal cord (SC), taking care not to damage the SC. Mice of the sham-operated group underwent 
laminectomy alone. Using a micro dissecting forceps, mice of the SCI group underwent right lateral 
hemisection at T9. Then, the muscle layer and the skin were sutured. After awaking fully from 
anesthesia, paralysis of the right hindlimb was assessed. The right hindlimb movement was not 
observed in this SCI model mice at the surgical day (day 0). At day 0, therefore, mice showing the 
movement of right hindlimb or with paraplegia were excluded from the following assessment and 
experiments. The urine was squeezed out by manual abdominal pressure on the bladder twice daily 
until reflex bladder function would be recovered. To determine the effect of a p38α inhibitor on SCI, 
each mouse received oral administration of SB239063 in acidified 0.5% tragacanth (10mg/kg per 
day; Sigma-Aldrich, St. Louis, MO) at 1, 2 and 3 dpi, and the control group received oral 
administration of vehicles, acidified 0.5% tragacanth. 
 
Behavior study 
We evaluated the motor function of the SCI-associated paralyzed hindlimbs from 0 to 28 days 
post-injury (dpi), based on Basso Mouse Scale (BMS) (Basso DM, et al., 2006). The BMS is a 9 
point scale for assessment of functional recovery of mice’s hindlimbs. Mice were forced to walk in 
an open field, and their right hindlimbs movement was observed for 4 minutes to score based on 
BMS. 
 
Tissue preparation and Histological analysis 
Mice were anesthetized lethally and transcardially perfused with ice-cold phosphate-buffered 
saline (PBS). SCs including the lesions were carefully dissected out, fixed overnight in 4% 
paraformaldehyde and subsequently immersed in 30% sucrose for 2 days to cryoprotect the tissues. 
After embedding into OCT compound, the samples were transversely or sagittally sectioned at a 
thickness of 20 µm. Sagittal and transverse sections were stained with hematoxylin-eosin (HE) and 
by a Kluver-Barrera’s (KB) method, respectively. The injury-associated leukocyte infiltration area 
and Luxol Fast Blue (LFB)-staining area in sections stained with HE and by a KB method, 
respectively, were quantified using Macromax MVC-DU (GOKO, Kanagawa, Japan). 
 
Tracing study 
For anterograde tracing of axons, a total of 2 µl of 10% Texas Red-conjugated biotinylated 
dextran amine (Texas Red-BDA; Vector Laboratries, Burlingame, CA) was injected into four sites 
of sensorimotor cortex in the left side (contralateral to the side of injured SC) at 14 dpi. The scalp 
was cut and a hole was carefully drilled into the skull, and then Texas Red-BDA was injected into 
the sensorimotor cortex using a 10 μl Hamilton microsyringe. The scalp was closed with suture. 
Mice applied with Texas Red-BDA were killed at 28 dpi. Sagittal sections (20 µm thick) from the 
SCs were observed by a fluorescence microscope (Axio Imager A2, Zeiss, Oberkochen, Germany). 
Texas Red-BDA-staining area in a visual field was quantified using ImageJ 1.45. 
 
Immunofluorescence study 
The freshly cut sagittal sections (20 µm thick) placed on poly-L-lysine-coated slides were 
pretreated with 1:10 FcR blocking agent (Miltenyi Biotech,Gladbach, Germany) for 10 min and 
reacted with various primary antibodies as follows: anti-CNPase (Sigma-Aldrich, St. Louis, MO) to 
label oligodendrocytes, anti-cleaved caspase-3 (Cell Signaling Tech., Beverly, MA) to label 
apoptotic cells, Cy3-conjugated anti-glial fibrillary acidic protein (GFAP; Sigma-Aldrich) to label 
astrocytes, anti-Iba1 (WAKO, Osaka, Japan) to label microglia or macrophages, Cy3-conjugated 
anti-NG2 (Merch Millipore, Billerica, MA) to label to oligodendrocyte precursors, 
FITC-conjugated anti-CD45.2 (Biolegend, San Diego, CA) to label leukocytes, biotin-labelled 
anti-CD3 (Affymetrix, Santa Clara, CA) to label T lymphocytes. After staining with each 
appropriate fluorescein-conjugated second antibody or streptavidin, 4’, 6-diamidino-2-phenylindole 
(DAPI) was applied for nuclear staining before the final washing step. The sections were observed 
by a fluorescence microscope. In case of counting cells immunoreacted with antibodies, 4-5 
sections from each SC were randomly selected. Under 200× magnification, two fields within 1 mm 
centered on the lesion epicenter in the SCI group or the corresponding segment in the 
sham-operated group were randomly chosen in each section, and fluorescent signal-expressing cells 
were counted and averaged (/0.1 mm
2
). 
 
Western blot array analysis 
Male WT and p38
+/-
 mice of the sham-operated and SCI groups were anesthetized and sacrificed 
at 7 dpi. Then, each unilateral SC in the right side including with the injured region was dissected 
out, and cut with the length of 6 mm from the edge of the rostral lesion to caudal side. The SC 
sample was homogenized, and centrifuged at 9000 x g for 20 min at 4˚C. The resulting supernatant 
was subjected to protein assay. Protein sample (60 µg/mouse) from five mice of each group 
(WT-sham, WT-SCI, p38
+/-
-sham, p38
+/-
-SCI) was mixed (300 µg in each group) and subjected to 
RayBio
®
 Biotin Label-based Mouse Antibody Array 1 (RayBiotech, Norcross, GA), and changes in 
expression levels of 308 inflammation-related proteins in the samples were evaluated. The array 
was performed according to the manufacturer’s instructions. Using a densitometer, each signal was 
normalized to the positive internal controls included in the array membrane and expressed as 
induction ratio of the sham-operated value. 
 
Statistical analysis 
All analyses were conducted through GraphPad Prism Version 6 (GraphPad Software, San Diego, 
CA). Statistical significance was determined by Mann-Whitney U test, Student’s t-test or analysis of 
variance (ANOVA) followed by Tukey’s test, and P-value of < 0.05 were considered to be 
significant. 
 
 
RESULTS AND DISCUSSION 
Recovery of hindlimb locomotor behavior related to histopathological findings in SC after SCI 
between p38α+/− and WT mice. 
We first addressed to whether a single copy disruption of p38α gene might affect functional 
recovery of hindlimb after lateral hemisection employed as SCI model in this study. Although such 
a laceration injury of SC is not typically seen clinically, a hemisection model is suitable to 
investigate the pathophysiological elements inhibiting or promoting axonal regeneration across or 
around the laceration injury as well as the resulting functional impairment and potential recovery 
(Onifer SM, et al., 2007). As shown in Fig. 1, p38α+/− mice showed significantly less severe 
neurological function of paralyzed SCI-associated right hindlimbs at 7 dpi, and then the more 
improved locomotor function in p38α+/− mice than in WT mice remained until 28 dpi. Therefore, a 
single copy disruption of p38α gene suppressed the functional disturbance in the hemisection model 
of SCI.  
Then, histopathological changes such as leukocytic infiltration-associated lesion area, myelinated 
area and axonal regeneration between the two genotypes were examined after SCI (Fig. 2). We 
calculated the leucocytic infiltration area using sagittal sections stained with HE at 1, 2 and 4 wpi 
(Fig. 2A, C). There was no significant difference in the size of leukocyte infiltration-associated 
lesion between the two genotypes at 1 wpi. The SCI-induced lesion was reduced in a 
time-dependent manner in the two genotypes at 2 and 4 wpi but significantly smaller in p38α+/− 
mice than in WT mice at each time point. These results suggest that the functional and 
histopathological recovery after SCI may be enhanced or accelerated in p38α+/− mice compared 
with WT mice. Remyelination of regenerated axons are likely to be one of key mechanisms 
involved in the spontaneous recovery of motor function after SCI (Lu P, et al., 2012). As shown in 
Fig. 2B, Luxol Fast Blue (LFB)-stained area on transverse section of the SC of the two genotypes 
was significantly smaller in the SCI group compared with the sham-operated group. And, the 
LFB-positive ratio was significantly larger in p38α+/− mice than in WT mice at 4 wpi (Fig. 2C). At 2 
wpi, the LFB-positive staining in the white matter of SC of the two genotypes was much weaker 
than the case at 4 wpi (data not shown), suggesting that axonal remyelination may occur at least 
over a time period ranging from 2 wpi to 4 wpi. Likewise, axons labeled by an anterograde tracer, 
Texas Red-BDA were more frequently observed in caudal part of the SC of p38α+/− mice than of 
WT mice at 4 wpi, a semi-quantitative analysis of which showed a significant difference between 
the both genotypes (Fig. 2D). The labeled frequency in rostral part of the SC was equally high 
between the two genotypes because axonal degeneration predominantly occurred in caudal part of 
the SC, and axons are intact in 5 mm rostral to the lesion epicenter of SC after the hemi-section 
injury. These results suggest that axonal regeneration and remyelination after SCI may be enhanced 
or accelerated in p38α+/− mice compared with WT mice. To elucidate the mechanism underlying the 
improved signs of SCI in p38α+/− mice, we focused on various pathological events at 1 and 2 wpi in 
which the difference in improvement of spontaneous locomotor ability after SCI between p38α+/− 
mice and WT mice was recognized and then manifested. 
 
Characterization of inflammatory response and evaluation of oligodendrocyte apoptosis 
between p38α+/− and WT mice at 1 wpi. 
A significant importance of leukocytes-mediated inflammatory reaction is well known in the 
development of SCI. In particular, T lymphocytes invade the lesion site, concomitantly to 
macrophages and secrete cytokines in the lesion epicenter, which results in axonal damage and 
motor neuron apoptosis after SCI (Beck KD, et al., 2010; Brunn A, et al., 2008). Moreover, a 
previous report demonstrated that the expression of p38 was enhanced in resident and infiltrating 
immune cell after SCI (Stirling DP, et al., 2008). Thus, we elucidated cell populations of leukocytes 
and T lymphocytes detected as CD45
+
 and CD3
+
, respectively in the lesion. As shown in Fig. 3A 
and B, CD45
+
 and CD3
+
 cells were observed in the lesion of the two genotypes at 1 wpi, each 
number of which was significantly lower in p38α+/- mice than WT mice. In general, neutrophils are 
a major cell population of CD45
+
 cells and contribute to both the progression of damage and the 
tissue repair after SCI (Neirinckx V, et al., 2014). However, Ly6G
+
 neutrophils were hardly detected 
in the lesion at 1 wpi (data not shown), which was supported by a previous report that neutrophil 
recruitment showed fast kinetics reaching a peak at 1 day and immediately declining to the baseline 
within several days (Donnelly DJ, et al., 2008). Considering cell types of leukocytes in the 
inflammation of SCI, thus, CD45
+
CD3
-
 cells in the lesion at 1 wpi may be mainly 
monocytes/macrophages. At the same time point, we also investigated the comprehensive analysis 
of SCI-induced change in expression of inflammation-related proteins in the SC. As shown in Fig. 
3C, we found 15 molecules (C-X-C motif chemokine 12 (CXCL12); Eotaxin-2; Galectin-3; 
insulin-like growth factor 2 (IGF-II), IL-2 receptor γ (IL-2Rγ); IL-9; IL-9 receptor (IL-9R); 
IL-12/p70; Kremen-1; macrophage inflammatory protein 1α (MIP-1α); MIP-2; matrix 
metalloproteinase 9 (MMP-9); Osteoactivin; tissue inhibitors of metalloproteinase 4 (TIMP-4); 
Toll-like receptor 2 (TLR2)) showing a clear difference in their expression between WT and p38α+/− 
mice. The lower expression of MIP-1α, MIP-2 and MMP-9 was corroborated as less leucocyte 
infiltration in the injured SC of p38α+/− mice (Jaerve A, et al., 2012). In particular, MMP-9 has been 
thought to open the blood-SC barrier and promote migration of leukocytes into the lesion, which 
may directly influence the severity of SCI (Noble LJ, et al., 2002). It has been also reported that 
MMP-9 and CXCL12 function synergistically to facilitate migration of blood-borne monocyte 
(Zhang H, et al., 2011), although CXCL12 has been regarded as one of key chemoattractants that 
regulates migration of homeostatic stem and progenitor cells in animal models of CNS injury and 
promote axonal sprouting (Jaerve A, et al., 2012). Therefore, it can be speculated that the decreased 
expression of both MMP-9 and CXCL12 in p38α+/− mice may lead to the less infiltrating leucocytes. 
Furthermore, MIP-1α and CXCL12 can recruit T lymphocytes into the injured site (Jaerve A, et al., 
2012; Ousman SS, et al., 2001). Thus, their decreased expression may be closely related to the 
reduction of T cell infiltration in p38α+/− mice.  On the other hand, Galectin-3 and TLR2 have been 
reported to have protective effects on SCI through regulating inflammatory response (Kigerl KA, et 
al., 2007; Stirling DP, et al., 2010; Gensel JC, et al., 2015; Mostacada K, et al., 2015). Among the 
15 molecules, only SCI-induced Galectin-3 was higher in p38α+/− mice compared with WT mice, 
suggesting that the increase of Galectin-3 may also contribute to the less infiltrating leucocytes in 
p38α+/− mice. Further study is needed to elucidate whether functional inhibition of each molecule by 
its neutralizing antibody affects the severity of SCI. However, the decrease in concomitant 
infiltration of monocytes/macrophages and T lymphocytes associated with the changes in 
expression of several cytokines/chemokines may contribute to the less development of SCI in 
p38α+/− mice. 
In central nerve system (CNS), p38 mainly localizes in myelin sheath but not in axon (Maruyama 
M, et al. 2000). It has been reported that inhibition of p38 prevents myelin structure destruction 
associated with oligodendrocytic apoptosis and ameliorates neurological deficits after SCI 
(Horiuchi H, et al., 2003). It has also been reported that apoptosis of oligodendrocyte would occur 
about 1 week after SCI and cause demyelination and axonal disturbance (Li U, et al., 1999; Dong H, 
et al., 2003). As a reliable strategy, colocalized cells of CNPase and cleaved caspase-3 are regarded 
as oligodendrocytes under programmed cell death in human SCI (Emery E, et al., 1998). Then, we 
evaluated a cell population of cleaved caspase-3
+
CNPase
+
 cells in the white matter of the lesion. As 
shown in Fig. 4, cleaved caspase-3
+
CNPase
+
 cells were typically observed in the SCI group of the 
two genotypes at 1 wpi (A), the number of which was significantly lower in p38α+/- mice than WT 
mice (B). On the other hand, Nissle
+
 neuronal cells decreased in the grey matter of SC around the 
lesion epicenter in the two genotypes at 1 wpi, which was significantly moderate in p38α+/- mice 
than WT mice (Supplementary Figure 1). These results indicated that p38α+/− mice showed 
resistance to cell death of oligodendrocytes and neurons at 1 wpi. Hence, the inflammatory 
responses and cell death of oligodendrocytes and neurons after SCI were reduced by a single copy 
disruption of p38α gene. Next, we elucidated a role of p38α in the tissue regeneration process after 
SCI. 
 
Astrocytic scar formation and increase in oligodendrocyte precursor cells after SCI between 
p38α+/− and WT mice. 
In a great numbers of studies, glial scar by reactive astrocytes has been regarded as physical 
barriers to successful axon regeneration (Silver J, et al., 2004). In contrast, recent studies have 
provided the possibility that reactive astrogliosis have beneficial effects in axonal regeneration via 
forming the astrocyte bridge, a scaffold for axonal growth (Anderson MA, et al., 2016; Mokalled 
MH, et al., 2016). On the other hand, activated microglias and macrophages markedly infiltrate into 
the lesion of CNS injury, the spread degree of which is closely associated with substantial tissue 
repair and functional restoration (Penkowa M, et al., 1999). Thus, the cellular formation of GFAP
+
 
astrocytes and Iba1
+
 microglias/macrophages between p38α+/− mice and WT mice was examined at 
2 wpi. As shown in Fig. 5, astrocytic scar formation was observed in the epicenter of the two 
genotypes, which was more massive in WT mice (B and C) than p38α+/− mice (F and G). Likewise, 
a larger numbers of reactive astrocytes with hypertrophied somas and long processes were observed 
in WT mice (D) than p38α+/− mice (H). These phenomena were supported by a previous study that 
astrogliosis after CNS damage might be attenuated in astrocyte-specific p38α-knockout mice (Roy 
Choudhury G, et al., 2014). On the other hand, Iba1
+
 microglias/macrophages were accumulated 
more compactly between rostrocaudal GFAP
+
 reactive astrocytes in p38α+/− mice than WT mice 
(Fig. 5B, C, F and G). Likewise, the distance between rostrocaudal glial scars was shorter in p38α+/− 
mice than WT mice (Fig. 5A and E), indicating that contraction of lesion area was enhanced in 
p38α+/− mice compared with WT mice. It has been reported that the Stat3-upregulated migratory 
activity of reactive astrocytes to seclude inflammatory cells enhances contraction of lesion area and 
functional restoration after SCI (Okada S, et al., 2006). Moreover, a loss of function of p38α in 
astrocyte negatively affects its cellular migration activity (Roy Choudhury G, et al., 2014). Thus, 
more typical compaction of microglias/macrophages associated with smaller wound area in p38α+/− 
mice compared with WT mice is of interest. Probably, at least the less infiltration of inflammatory 
cells related to expression of proinflammatory cytokines (Fig. 3) may positively affect the wound 
healing process in p38α+/− mice even though astrogliosis-forming activity is moderate compared 
with WT mice. In addition, it was also provided the possibility that the contribution of neural stem 
cells (NSCs) to wound healing/tissue regeneration process after SCI might be potentiated in p38α+/− 
mice.  
Multipotent NSCs are defined as cells that can self-renew and differentiate into the three neuronal 
lineages, neuron, astrocyte and oligodendrocyte (Gage FH, 2000). In the SC, NSCs known as 
ependymal cells in the central canal proliferate rapidly after SCI and differentiate into more than 
half the astrocytes in the glial scar and a small amount of oligodendrocytes (Barnabé-Heider F, et al, 
2010). Likewise, in vitro, NSCs derived from adult WT mice easily and exclusively differentiate 
into astrocyte with repeating cell passages without appropriate neurotrophic factors (Bull ND, et al., 
2005; Seaberg RM, et al., 2002). Hence, the low differentiation capacity of adult NSC for neural 
and oligodendrocytic lineages can limit the recovery from SCI. We previously reported that NSCs 
in the adult hippocampus of p38α+/- mice have much higher self-renewal activity and neural 
differentiation capacity compared with those of WT mice (Yoshioka K, et al., 2015). These findings 
tempted us to think that activity of progenitor cells for oligodendrocyte and neuron might be 
upregulated in p38α+/− mice under the tissue regeneration process after SCI. To elucidate this point, 
we observed cell populations of oligodendrocyte precursor cells and neural progenitor cells in the 
lesion epicenter of SC at 2 wpi. As we expected, the number of NG2
+
 oligodendrocyte precursor 
cells (OPCs) in the white matter of the lesion increased in the two genotypes at 2 wpi, which was 
significantly higher in p38α+/− mice than in WT mice (Fig. 6). NG2+ OPCs into the injured SC can 
enhance remyelination of spared axons and improve functional recovery after SCI (Whittaker MT, 
et al., 2012). Thus, in conjunction with the results shown in Fig. 2B and C, the increase in OPCs in 
p38α+/− mice after SCI may contribute to the efficiency of remyelination under the tissue 
regeneration process. We also determined that NG2
+
 cells were more accumulated along the 
laceration/epicenter in p38α+/− mice compared with WT mice (data not shown). This accumulation 
was very similar to typical histopathological findings in CNS damages including SCI (Tan AM, et 
al., 2005). NG2 is a member of chondroitin sulphate proteoglycans (CSPGs) generally known to be 
repulsive to growing axons. However, NG2 also called CSPG4 has been recently recognized as a 
promoting molecule for axonal growth and regeneration (Yang Z, et al., 2006). In fact, it has been 
demonstrated that astrocytes forming a bridge across a scar after SCI highly express CSPG4/NG2 
(Anderson MA, et al., 2016). Likewise, NG2
+
 OPCs provide an adhesive substrate for axonal 
growth by forming a bridge after SCI (Busch SA, et al., 2010). Although we could not detected the 
astrocytic bridge between rostrocaudal glial scars in the two genotypes (Fig. 5), the fact that 
accumulation of NG2
+
 OPCs along the laceration/epicenter was more apparent in p38α+/− mice 
compared with WT mice might affect the efficiency of axonal regeneration between the two 
genotypes. In addition to the upregulation of OPC recruitment in p38α+/− mice, an increase in DCX+ 
neural progenitor cells in the grey matter of the lesion was bigger in p38α+/− mice than in WT mice 
at 2 wpi. Some of the DCX
+
 neural progenitor cells also expressed Nestin and were observed in area 
proximal to the lesion epicenter in the two genotypes. Notably, DCX
+
Nestin
+
 cells were also 
detected within the epicenter in case of p38α+/− mice but not WT mice (Supplementary Figure 2).  
DCX
+
Nestin
+
 cells have been identified as resident multipotent NSCs in the SC meninges and at 
least contribute to parenchymal reaction following SCI (Decimo I, et al., 2011). Although it is still 
unclear whether the DCX
+
Nestin
+
 cells recruited into the lesion contribute to neural regeneration, 
the finding that recruitment of neuroblasts and resident NSCs to the lesion was upregulated in 
p38α+/− mice may affect the subsequent tissue regeneration in concert with the enhanced 
recruitment of OPCs. 
Together, a single copy disruption of p38α gene affected the tissue degeneration and regeneration 
processes and improved the functional recovery from SCI. However, the question arose as to 
whether the SCI-augmented p38 activation was inhibited in the SC of p38α+/− mice. Although SCI 
did not affect each expression level of p38α in the two genotypes, the SCI-augmented p38 
activation was less in p38α+/− mice compared with WT mice (Supplementary Figure 3). Therefore, 
we finally evaluated the effect of a p38 inhibitor on the functional recovery from SCI.  
 
A p38 inhibitor improved locomotor recovery after SCI. 
Unlike the previous studies on the association between SCI and a p38 inhibitor (Horiuchi H, et al., 
2003; Stirling DP, et al., 2008), we used SB239063 as a p38 inhibitor that is an orally active and 
transferable across the blood-cerebrospinal fluid barrier. In the preliminary study, we confirmed that 
an oral administration of SB239063 (10 mg/kg body weight) could efficiently inhibit the 
SCI-induced p38α activity (Supplementary Figure 4). Then, based on a previous report that the 
strong activation of p38 MAPK in the injured SC increases from 12 hour to 3 days (Song Y, et al., 
2013), we orally administrated SB239063 to WT mice (10 mg/kg per day) at 1, 2 and 3 dpi. As we 
expected, the BMS score was significantly higher in the SB239063-treated group compared with the 
vehicle group over a time period ranging from 6 dpi to 28 dpi (Fig. 7), indicating that a 
pharmacological inhibition of p38α also improved the recovery of hindlimb behaivior after SCI. 
Our present result that SB239063 is effective on the functional recovery after lateral hemisection 
of the SC can be supported by the previous study employing a mild contusion model of SCI by 
Horiuchi H, et al. (Horiuchi H, et al., 2003). On the other hand, another study demonstrated that a 
p38α inhibitor failed to improve functional outcome after SCI with moderate contusion (Stirling DP, 
et al., 2008). Currently, the discrepancy in efficacy of a p38α inhibitor for SCI between them is 
difficult to explain. Regardless of the type of SCI model, however, the intensity of SC damage may 
influence the beneficial effect of a p38α inhibitor. In addition, the route and schedule of 
administration with a p38α inhibitor also affect its efficacy. As a next step, to investigate whether 
our protocol of SB239063 administration is effective in a moderate contusion model of SCI is 
needed. 
 
CONCLUSION 
A single copy disruption of p38α gene inhibited the tissue degenerative events such as leukocytic 
infiltration, expression of cytokines/chemokines and apoptosis of oligodendrocyte and neuron and 
enhanced the tissue regenerative events such as compaction of microglias/macrophages, recruitment 
of OPCs and NSC and axonal regrowth and remyelination, which resulted in a better functional 
recovery from SCI. We also demonstrated that a pharmacological inhibition of p38α could 
recapitulate the better functional recovery from SCI observed in p38α+/− mice. Our present study 
clearly suggests that p38α contributes to the pathogenesis of SCI and propose that an orally active 
p38α inhibitor, SB239063 may have therapeutic benefits for the treatment of SCI. 
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FIGURE LEGENDS 
 
Figure 1. Time course of hindlimb locomotor behavior after SCI. WT and p38α+/- mice with SCI 
were observed daily until 28 dpi, and scored based on BMS. Data are shown as mean ± S.E.M (n = 
5). The difference between WT (filled squares) and p38α+/- (open circles) mice was statistically 
significant (*P < 0.05) as determined by Mann-Whitney U test for unpaired values at each time 
point.   
 
Figure 2. Histopathological changes after SCI. (A) Typical profiles of HE-stained sagittal SC 
sections from WT and p38α+/- mice at 1, 2, 4 weeks post-injury. (B) Transverse SC sections from 
WT and p38α+/- mice at 4 weeks post-injury (1 mm caudal of the lesion epicenter) or with 
sham-operation (the corresponding site) were stained by a KB method. LFB-staining area was 
surrounded with the dotted lines. (C) Quantitative evaluation of A and B. Left column, 
SCI-associated leukocyte infiltration into SC of WT (open bars) and p38α+/- (closed bars) mice. 
Right column, ratio of LFB-staining area to right hemi-SC area in WT (open bars) and p38α+/- 
(closed bars) mice. Data are shown as mean ± S.E.M (n = 5). *P < 0.05 (ANOVA followed by 
Tukey's test), 
#
P < 0.05 (Student’s t test for unpaired values). (D) Representative images of Texas 
Red-BDA-labeled axons in the white matter of SC of WT and p38α+/- mice at 4 weeks post-injury. 
In the SCI group, sagittal sections of SC at 5 mm rostral and 5 mm caudal to the lesion epicenter 
were observed. In the sham-operated group, SC segment corresponding to the lesion epicenter (T9) 
of the SCI group was observed. Texas-Red BDA staining area caudal to the lesion epicenter was 
expressed as the percentage of the whole field. Data are shown as mean ± S.E.M (n = 5). *P < 0.05 
(Student’s t test for unpaired values). 
 
Figure 3. Inflammatory profiles 1 week after SCI (A) Typical profile of CD3
+
CD45
+
 cells in the 
lesion epicenter of the two genotypes at 1 week post-injury. Asterisks indicate double-positive cells. 
(B) Quantitative evaluation of A. CD3
+
 cells and CD45
+
 cells in the injured site within 500 µm 
rostrocaudal of the lesion epicenter increased in both WT (open bars) and p38α+/- (closed bars) mice 
at 1 week post-injury, the number of which was significantly lower in p38α+/- mice than WT mice. 
Data are shown as mean ± S.E.M. (n = 5). *P < 0.05 (ANOVA followed by Tukey's test). (C) 
SCI-induced changes in expression of cytokines in the SC between WT and p38α+/- mice. Collected 
SC protein sample from five mice of each group (WT-sham, WT-SCI, p38α+/--sham or p38α+/--SCI) 
were subjected to protein array for 308 molecules. Three independent experiments were conducted 
(15 mice in each group). Using a densitometer, each signal was normalized to the positive internal 
controls included in the array membrane (P1-a), and expressed as induction ratio of the 
sham-operated value. Among 61 molecules (≥ 2, induction ratio in WT group), 15 molecules 
showed a significant difference in their induction ratio between the two genotypes. Data are shown 
as mean ± S.E.M. (n = 3). The difference between WT (open squares) and p38α+/- (filled squares) 
mice was statistically significant (*P < 0.05) as determined by Student’s t test for unpaired values. 
 
Figure 4. Changes in numbers of apoptotic oligodendrocytes in the white matter 1 week after 
SCI. (A) Typical profile of cleaved caspase-3
+
CNPase
+
 cells in the white matter at the caudal 
boarder of the lesion of the two genotypes at 1 week post-injury. Asterisks indicate double-positive 
cells. (B) Cleaved caspase-3
+
CNPase
+
 cells in the injured site within 500 µm rostrocaudal of the 
lesion epicenter increased in both WT (open bars) and p38α+/- (closed bars) mice at 1 week 
post-injury, the number of which was significantly lower in p38α+/- mice than WT mice. Data are 
shown as mean ± S.E.M. (n = 4-5). *P < 0.05 (ANOVA followed by Tukey's test). 
 
Figure 5. Astrocytic scar formation and neuroinflammation-associated cells at 2 weeks 
post-injury. (A, E) Representative images of sagittal sections showing GFAP
+
 reactive astrocytes 
and Iba1
+
 cells at 2 weeks post-injury. (B, C, F, G) Higher magnification images from the boxed 
area, b, c, f and g in A and E. Iba1
+
 cells were compacted to the lesion center between rostrocaudal 
reactive astrocytes, which was more apparent in the SC of p38α+/− mice than that of WT mice. (D, 
H) Higher magnification images of GFAP
+
 reactive astrocytes from the boxed area, d (in A) and h 
(in E). GFAP
+
 reactive astrocytes at 1mm caudal to the lesion epicenter decreased in p38α+/− mice 
compared with WT mice.  
 
Figure 6. Change in numbers of NG2
+
 cells in the white matter at 2 weeks after SCI. (A) 
Typical profile of NG2
+
 cells in the lesion epicenter of the two genotypes at 2 weeks post-injury. 
(B) NG2
+
 cells in the injured site within 500 µm rostrocaudal of the lesion epicenter in the SCI 
group were increased in the two genotypes at 1 week post-injury, the number of which was 
significantly higher in p38α+/- mice (closed bars) than WT mice (open bars). Data are shown as 
mean ± S.E.M. (n = 4-5). *P < 0.05 (ANOVA followed by Tukey's test). 
 
Figure 7. Effect of SB239063 on hindlimb locomotor behavior after SCI. WT mice with SCI 
received oral administration of vehicles (filled squares) and SB239063 (10 mg/kg per day, filled 
circles) at 1, 2 and 3 dpi. Functional recovery from SCI was better in mice with SB239063 
treatment than those with vehicle administration. Data are shown as mean ± S.E.M (n = 6). *P < 
0.05, a significant difference between the two groups by Mann-Whitney U test for unpaired values 
at each time point. 
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Supplementary Figure 1 
 
 
Changes in numbers of Nissle
+
 neural cells in the grey matter of spinal cord after SCI. A) 
Typical profiles of Nissle
+
 neural cells in the lesion epicenter of WT and p38α+/- mice at 1 week 
after SCI are shown. B) Quantitative evaluation of Nissle
+
 neural cells between the two genotypes 
was performed with or without SCI. Data are shown as mean ± S.E.M. (n=4-5). *P < 0.05 (ANOVA 
followed by Tukey’s test). Sagittal sections (20 µm in thickness) of the spinal cords were prepared 
from the two genotypes at 1 week after operation (sham-operation or hemisection) and subjected to 
staining with Nissle reagent (BrainStain Imaging Kit, Thermo Fisher Scientific). Nuclei were 
stained with 4',6-Diamidino-2-phenylindole, dihydrochloride (DAPI). The lesioned area between 
500 µm rostral and 500 µm caudal of the lesion epicenter in the SCI group and the corresponding 
area in the sham-operated group were observed by a fluorescent microscopy (AXIO Imager A2, 
Carl Zeiss).   
Supplementary Figure 2 
 
 
Changes in numbers of doublecortin (DCX)
+
 neural progenitor cells in the grey matter of 
spinal cord after SCI. A) DCX
+
 neural progenitor cells increased 2 weeks after SCI, which was 
significantly greater in p38α+/- mice compared with WT mice. The area between 500 µm rostral and 
500 µm caudal of the lesion epicenter in the SCI group and the corresponding area in the 
sham-operated group were observed. Data are shown as mean ± S.E.M. (n=4-5). *P < 0.05 
(ANOVA followed by Tukey’s test). B) Some of the DCX+ neural progenitor cells appeared to be 
Nestin
+
 simultaneously. DCX
+
Nestin
+
 cells were also observed in area proximal to the lesion 
epicenter of the two genotypes. Notably, DCX
+
Nestin
+
 cells were observed within the epicenter in 
not WT mice but p38α+/- mice. Sagittal sections (20 µm in thickness) of the spinal cords were 
prepared from the two genotypes at 2 weeks after operation (sham-operation or hemisection) and 
subjected to immunofluorescent study with anti-DCX (C-18, Santa Cruz Biotech.) and anti-Nestin 
(Sigma-Aldrich) antibodies. Nuclei were stained with DAPI. 
Supplementary Figure 3 
 
 
 
Effects of SCI on protein level and activation of p38α in the two genotypes. Protein samples 
used in Western blot array (Fig. 3C) were subjected to Western blot analyses with anti-phospho p38, 
anti-p38α (Cell Signaling Technology, Danvers, MA) and anti-β-actin (Sigma-Aldrich). Similar 
results were obtained from three independent experiments. 
 
 
 
 
 
 
 
 
Supplementary Figure 4 
 
 
 
Inhibitory effect of SB239063 on the SCI-induced p38α activity. Mice were orally administered 
with SB239063 (10 mg/Kg) or vehicle (acidified 0.5% tragacanth) 24 h after the operation 
(Sham-operation or SCI). Then, protein samples were prepared from the SCs 36 h after the 
operation. Each protein sample (200 μg) was subjected to the immunoprecipitation with anti-p38α 
antibody (Ref.: Maruyama M, et al. 2000) in combination with protein A/G-agarose (Calbiochem, 
San Diego, CA). After washing with a kinase buffer, the immunoprecipitates were mixed with 200 
μM ATP and 2 μg GST-ATF-2 fusion protein as a substrate in 30 μl of kinase buffer and incubated 
for 45 min at 30°C. The kinase reaction was terminated by adding an appropriate volume of SDS 
sample buffer. The phosphorylation of ATF-2 was determined by Western blot analysis with 
anti-phospho-ATF-2 (Thr71) antibody (Cell Signaling Technology). As an internal control, the 
amount of immunoprecipitated p38α was determined by Western blot analysis with anti-p38α 
antibody (Cell Signaling Technology). Similar results were obtained from two independent 
experiments. 
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